Rethinking Beta Blockers in HCM

from Tales from the Heart · host Hypertrophic Cardiomyopathy Association / Lisa Salberg

Lisa Salberg and Dr. Martin Maron take a fresh look at the long-standing role of beta blockers in HCM and how newer myosin inhibitors are changing the treatment conversation. They also discuss upcoming clinical data, fibrosis, symptom changes, and how patients can better navigate evolving care. This conversation was recorded Aug. 14, 2026

Episode metadata supplied by the publisher feed · Published Sep 1, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Rethinking Beta Blockers in HCM

0:00 51:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Tales from the Heart?

This episode is 51 minutes long.

When was this Tales from the Heart episode published?

This episode was published on September 1, 2026.

Can I download this Tales from the Heart episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!